NYSE:CLB Core Laboratories (CLB) Stock Price, News & Analysis $11.96 +0.55 (+4.78%) Closing price 03:59 PM EasternExtended Trading$11.90 -0.06 (-0.50%) As of 07:34 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Core Laboratories Stock (NYSE:CLB) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Core Laboratories alerts:Sign Up Key Stats Today's Range$11.28▼$12.2150-Day Range$10.78▼$14.5252-Week Range$9.72▼$20.36Volume930,916 shsAverage Volume1.24 million shsMarket Capitalization$551.09 millionP/E Ratio18.39Dividend Yield0.33%Price TargetN/AConsensus RatingReduce Company Overview Core Laboratories N.V. is a global provider of proprietary and patented reservoir description and production enhancement services to the oil and gas industry. The company applies specialized expertise in core and fluid analysis, advanced petrophysical interpretation, and reservoir engineering to optimize hydrocarbon recovery. By integrating laboratory testing with field services and digital analytics, Core Laboratories delivers insights that help operators maximize production and extend the life of their assets. The company’s portfolio spans two primary service lines: reservoir description and production enhancement. In reservoir description, Core Laboratories performs detailed analyses on drill-cuttings, cores and reservoir fluids to characterize rock and fluid properties. Under production enhancement, the company offers well stimulation, downhole chemistry, and scale and corrosion management solutions designed to improve flow rates and mitigate operational risks. These services are supported by a global network of research laboratories and field service centers equipped with advanced instrumentation. Headquartered in Amsterdam with key operating offices in Houston, Core Laboratories conducts business in more than 50 countries across six continents, serving major international and national oil companies, as well as independents. The company’s engineering and technical teams collaborate closely with clients to tailor solutions to diverse reservoir environments. Under the leadership of President and CEO Clay C. Williams, Core Laboratories continues to invest in innovation and technology development to address evolving challenges in reservoir management and production optimization.AI Generated. May Contain Errors. Read More Core Laboratories Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks32nd Percentile Overall ScoreCLB MarketRank™: Core Laboratories scored higher than 32% of companies evaluated by MarketBeat, and ranked 210th out of 254 stocks in the energy sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion1.0 / 5Analyst RatingReduce Consensus RatingCore Laboratories has received a consensus rating of Reduce. The company's average rating score is 1.50, and is based on no strong buy ratings, no buy ratings, 1 hold rating, and 1 sell rating.Amount of Analyst CoverageCore Laboratories has only been the subject of 1 research reports in the past 90 days.Read more about Core Laboratories' stock forecast and price target. Earnings and Valuation3.1 / 5Proj. Earnings Growth49.06% Earnings GrowthEarnings for Core Laboratories are expected to grow by 49.06% in the coming year, from $0.53 to $0.79 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Core Laboratories is 18.39, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 45.82.Price to Earnings Ratio vs. SectorThe P/E ratio of Core Laboratories is 18.39, which means that it is trading at a less expensive P/E ratio than the Energy sector average P/E ratio of about 19.89.Price to Earnings Growth RatioCore Laboratories has a PEG Ratio of 2.75. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioCore Laboratories has a P/B Ratio of 2.04. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Core Laboratories' valuation and earnings. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted13.12% of the float of Core Laboratories has been sold short.Short Interest Ratio / Days to CoverCore Laboratories has a short interest ratio ("days to cover") of 5.78.Change versus previous monthShort interest in Core Laboratories has recently increased by 7.85%, indicating that investor sentiment is decreasing significantly. Dividend1.7 / 5Dividend StrengthWeak Dividend YieldCore Laboratories has a dividend yield of 0.35%, which is in the bottom 25% of all stocks that pay dividends.Dividend GrowthCore Laboratories does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Core Laboratories is 6.15%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, Core Laboratories will have a dividend payout ratio of 5.06% next year. This indicates that Core Laboratories will be able to sustain or increase its dividend.Read more about Core Laboratories' dividend. News and Social Media1.9 / 5News Sentiment0.00 News SentimentCore Laboratories has a news sentiment score of 0.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.75 average news sentiment score of Energy companies.News Coverage This WeekMarketBeat has tracked 6 news articles for Core Laboratories this week, compared to 2 articles on an average week. Company Ownership0.8 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Core Laboratories insiders have not sold or bought any company stock.Percentage Held by Insiders1.26% of the stock of Core Laboratories is held by insiders.Percentage Held by Institutions97.81% of the stock of Core Laboratories is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Core Laboratories' insider trading history. Receive CLB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Core Laboratories and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CLB Stock News HeadlinesWhat is Zacks Research's Forecast for CLB FY2027 Earnings?July 20 at 1:58 AM | americanbankingnews.comCORE LABORATORIES ANNOUNCES TIMING OF SECOND QUARTER 2026 EARNINGS RELEASE AND CONFERENCE CALLJune 30, 2026 | prnewswire.comChina is stealing your bank recordsU.S. intelligence calls it Q-Day - the moment a quantum computer comes online and today's encryption becomes worthless. Chinese hackers are already stockpiling encrypted American bank records, wire instructions, and account credentials, warehousing them until that day arrives. Citi research estimates a single attack on one bank could trigger more than $3 trillion in fallout. Washington is racing to build quantum-resistant security - and one small-cap company may be positioned at the center of that effort.July 22 at 1:00 AM | Behind the Markets (Ad)Noble Corporation, Valaris, and Core Laboratories shares plummet, what you need to knowJune 16, 2026 | msn.comCore Laboratories and Helmerich & Payne shares are soaring, what you need to knowJune 10, 2026 | msn.comTETRA Technologies and Core Laboratories shares skyrocket, what you need to knowJune 8, 2026 | msn.comWinners and losers of Q1: Core Laboratories (NYSE:CLB) vs the rest of the oilfield services stocksJune 5, 2026 | msn.comThese 10 small-cap energy stocks carry the market's least attractive valuationsJune 2, 2026 | seekingalpha.comSee More Headlines CLB Stock Analysis - Frequently Asked Questions How have CLB shares performed this year? Core Laboratories' stock was trading at $16.02 at the start of the year. Since then, CLB shares have decreased by 25.4% and is now trading at $11.9550. How were Core Laboratories' earnings last quarter? Core Laboratories Inc. (NYSE:CLB) issued its earnings results on Wednesday, April, 29th. The oil and gas company reported $0.06 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.06. The firm's revenue for the quarter was down 1.4% on a year-over-year basis. Read the conference call transcript. Who are Core Laboratories' major shareholders? Core Laboratories' top institutional shareholders include GAMMA Investing LLC (0.01%). View institutional ownership trends. How do I buy shares of Core Laboratories? Shares of CLB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Core Laboratories own? Based on aggregate information from My MarketBeat watchlists, some other companies that Core Laboratories investors own include Humana (HUM), American Water Works (AWK), Waste Connections (WCN), Voyager Therapeutics (VYGR), The RMR Group (RMR), AUO (AUOTY) and DiamondRock Hospitality (DRH). Company Calendar Last Earnings4/29/2026Record date for 6/1 Dividend5/11/2026Ex-Dividend for 6/1 Dividend5/11/2026Dividend Payable6/01/2026Today7/22/2026Next Earnings (Estimated)7/29/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (1m+) 1-Year History Jul 25 Oct 25 Jan 26 Apr 26 Jul 26 CLB's financial health is in the Red zone, according to TradeSmith. CLB has been in this zone for over one month. Industry, Sector and Symbol Stock ExchangeNYSE SectorEnergy Industry OIL - FIELD SVCS Sub-IndustryPetroleum And Natural Gas Current SymbolNYSE:CLB CIK1958086 Webwww.corelab.com Phone(713) 328-2673FaxN/AEmployees3,300Year Founded1936Profitability EPS (Trailing Twelve Months)$0.65 Trailing P/E Ratio18.39 Forward P/E Ratio22.56 P/E Growth2.75Net Income$29.67 million Net Margins5.94% Pretax Margin8.21% Return on Equity11.52% Return on Assets5.32% Debt Debt-to-Equity Ratio0.42 Current Ratio2.05 Quick Ratio1.50 Sales & Book Value Annual Sales$524.73 million Price / Sales1.05 Cash Flow$1.12 per share Price / Cash Flow10.68 Book Value$5.85 per share Price / Book2.04Miscellaneous Outstanding Shares46,097,000Free Float45,516,000Market Cap$551.09 million OptionableOptionable Beta1.00 Social Links The Best Nuclear Energy Stocks to BuyNuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.Get This Free Report This page (NYSE:CLB) was last updated on 7/22/2026 by MarketBeat.com Staff. From Our PartnersElon says “don’t save money.” Is he right?Robert Kiyosaki, author of Rich Dad Poor Dad, says you don't have to wait for Elon Musk's vision of universal ...Freedom Financial | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredBlackRock is hoarding it. JPMorgan is hoarding it. Do you own it?BlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...Awesomely | SponsoredThe Starlink of EnergyA portable energy unit - already used by the U.S. Navy for decades - is now drawing serious attention from Big...Monument Traders Alliance | SponsoredA letter from Shannon StansberryPorter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...Porter & Company | SponsoredElon is about to dominate the biggest arms race in tech historyMicrosoft, Amazon, Alphabet, and Meta have collectively poured nearly $700 billion into AI infrastructure in 2...The Oxford Club | SponsoredA Secret Plan to End Trump in November?A White House insider with close ties to the Trump family is speaking out about what he calls the biggest poli...Paradigm Press | SponsoredIt all happens tonight.Tonight, trader Sean Allison is hosting a live session to walk through his Zero-Dollar Trade Advantage strateg...Trade Thirsty | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Core Laboratories Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Core Laboratories With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
